Cargando…
Targeting the TREM1-positive myeloid microenvironment in glioblastoma
BACKGROUND: Tumor cellular and molecular heterogeneity is a hallmark of glioblastoma and underlies treatment resistance and recurrence. This manuscript investigated the myeloid-derived microenvironment as a driver of glioblastoma heterogeneity and provided a pharmacological pathway for its suppressi...
Autores principales: | Filippova, Natalia, Grimes, Jeffrey M, Leavenworth, Jianmei W, Namkoong, David, Yang, Xiuhua, King, Peter H, Crowley, Michael, Crossman, David K, Nabors, L Burt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555298/ https://www.ncbi.nlm.nih.gov/pubmed/36249290 http://dx.doi.org/10.1093/noajnl/vdac149 |
Ejemplares similares
-
Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma
por: Dees, Kory J, et al.
Publicado: (2021) -
Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing
por: Li, Chao, et al.
Publicado: (2022) -
Multireceptor targeting of glioblastoma
por: Sharma, Puja, et al.
Publicado: (2020) -
Radiogenomic modeling predicts survival-associated prognostic groups in glioblastoma
por: Nuechterlein, Nicholas, et al.
Publicado: (2021) -
Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect
por: Gibson, David, et al.
Publicado: (2023)